Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

SNX31 Inhibitors

SNX31 inhibitors refer to a class of chemical compounds designed to target and modulate the activity of the Sorting Nexin 31 (SNX31) protein. SNX31 is a member of the Sorting Nexin (SNX) family, which is primarily involved in regulating intracellular trafficking and endosomal sorting processes within cells. These inhibitors have garnered attention due to their to influence the cellular pathways and functions mediated by SNX31. SNX31, like other SNX proteins, plays a pivotal role in the intricate processes of endocytosis and endosomal sorting. It is known to interact with various endosomal proteins and membrane lipids, contributing to the maintenance of cellular homeostasis and vesicular trafficking.

SNX31 inhibitors are designed to interfere with the normal function of SNX31 by binding to the protein or altering its conformation. By doing so, they can impact the sorting and trafficking of membrane-bound proteins, receptors, and other cellular cargo within endosomes. This can have downstream effects on various cellular processes, including receptor signaling, protein degradation, and recycling. Researchers are particularly interested in understanding the specific mechanisms through which SNX31 inhibitors modulate endosomal sorting and their implications for cell physiology and pathology. As the field of cell biology continues to unravel the intricacies of endosomal trafficking and protein sorting, SNX31 inhibitors may prove to be valuable tools for studying these processes and uncovering novel insights into cellular regulation.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Inhibits PI3-kinases, blocking phosphoinositide signaling.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

Blocks PI3-kinase activity, disrupting PI3K/Akt signaling.

IC-87114

371242-69-2sc-364509
sc-364509A
5 mg
50 mg
$140.00
$1060.00
1
(1)

Selective inhibitor of PI3Kδ, affecting B-cell signaling.

CAL-101

870281-82-6sc-364453
10 mg
$193.00
4
(1)

Targets PI3Kδ, primarily in lymphocytes, for cancer therapy.

BAY 80-6946

1032568-63-0sc-503264
5 mg
$562.00
(0)

Dual PI3K/mTOR inhibitor, impeding PI3K/Akt/mTOR signaling.

AZD5363

1143532-39-1sc-503190
5 mg
$309.00
(0)

Blocks Akt kinase activity, suppressing downstream pathways.

GDC-0941

957054-30-7sc-364498
sc-364498A
5 mg
10 mg
$188.00
$199.00
2
(1)

Selective PI3K inhibitor disrupting PI3K/Akt/mTOR signaling.

GDC-0980

1032754-93-0sc-364499
sc-364499A
5 mg
50 mg
$347.00
$1428.00
(0)

Inhibits both PI3K and mTOR, impacting multiple pathways.

BYL719

1217486-61-7sc-391001
sc-391001A
sc-391001B
sc-391001C
sc-391001D
sc-391001E
5 mg
10 mg
50 mg
100 mg
500 mg
1 g
$391.00
$597.00
$755.00
$1192.00
$5000.00
$9370.00
2
(0)

Selective PI3Kα inhibitor used for breast cancer

PI 3-Kβ Inhibitor VI, TGX-221

663619-89-4sc-203190
1 mg
$437.00
(0)

Inhibits PI3Kβ, affecting Akt signaling in specific cancers.